Zobrazeno 1 - 10
of 118
pro vyhledávání: '"Aljoša, Kandus"'
Autor:
Tanja Belčič Mikič, Gregor Mlinšek, Manca Oblak, Aljoša Kandus, Jadranka Buturović-Ponikvar, Simon Hawlina, Tomaž Milanez, Nika Kojc, Maja Frelih, Miha Arnol
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
We present two cases of transmission of a pancreatic adenocarcinoma from a single donor to two kidney transplant recipients. Autopsy of the donor revealed a pancreatic adenocarcinoma that had already spread locally to the regional lymph nodes and had
Externí odkaz:
https://doaj.org/article/b29c832f1bec4ecf8c84ba066c9e1a2a
Publikováno v:
Zdravniški Vestnik, Vol 81, Iss 10 (2012)
Secondary hyperparathyroidism (SHPT) is one of the major complications of chronic kidney disease (CKD). It results from the combination of many events, starting with deficiency of 1,25 dihydroxycholecalciferol (activated vitamin D), decreased act
Externí odkaz:
https://doaj.org/article/09908d41742b40c7aa7a39ba881094fa
Publikováno v:
Transplant International. 31:1391-1404
Proteinuria after kidney transplantation is accompanied by an increased risk of graft failure. In this single-center, placebo-controlled, double-blind trial we studied whether vitamin D receptor activator paricalcitol might reduce proteinuria. Patien
Autor:
Andreja Bren, Aljoša Kandus
Publikováno v:
Zdravniški Vestnik, Vol 79, Iss 12 (2010)
Externí odkaz:
https://doaj.org/article/c639919d88b941e0b9eaaf270cb4a0a3
Publikováno v:
Clinical Nephrology. 88:119-125
AIMS Paricalcitol, a selective vitamin D activator, decreases proteinuria and may reduce graft failure risk in kidney transplant recipients. In this study, we evaluated the effect of paricalcitol on renin-angiotensin system (RAS) activity as well as
Autor:
Miha Arnol, Rafael Ponikvar, Damjan Kovač, Jadranka Buturović-Ponikvar, Andreja Aleš Rigler, Jakob Gubensek, Karmen Romozi, Aljoša Kandus, Jelka Lindič
Publikováno v:
Therapeutic Apheresis and Dialysis. 20:240-245
Antibody-mediated rejection (AMR) is a major cause of kidney graft failure. We aimed to analyze treatment and outcome of AMR in a national cohort of 75 biopsy-proven acute (43 patients, 57%) or chronic active (32 patients, 43%) AMR episodes between 2
Autor:
Jakob Gubensek, Dimitrij Klančič, Senka Černe, Natalija Kunc-Rešek, Robert Ekart, Marko Malovrh, Miha Arnol, Gregor Novljan, Jadranka Buturović-Ponikvar, Aljoša Kandus, Igor Rus, Karmen Romozi, Sonja Kapun, Andrej Čufer, Bojan Knap, Bojan Vujkovac, Silvan Saksida, Rafael Ponikvar, Tone Adamlje, Stojan Kralj, Gabriela Damevska, Andrej Drozg, Zlata Ceglar, Mateja Globokar, Simona Kralj-Lopert, Marjan Močivnik
Publikováno v:
Therapeutic Apheresis and Dialysis. 20:223-228
This report provides a summary of the 2013 Slovenian renal replacement therapy (RRT) data, obtained from 24 renal centers: 23 dialysis and one transplant center, referring from 31 December 2013, with 100% response rate to individual patient questionn
Publikováno v:
Therapeutic Apheresis and Dialysis. 20:312-317
Renal transplantation is the optimal renal replacement therapy (RRT) in children, but some primary diseases can recur after transplantation, and recurrence accounts for a significant proportion of graft losses, being second only to acute rejection. T
Publikováno v:
Therapeutic Apheresis and Dialysis. 20:229-233
This report gives an overview of kidney transplantation in Slovenia, a country with a population of 2.1 million and one transplant center. The establishment of a national transplant organization resulted in the acceptance of Slovenia into Eurotranspl
Publikováno v:
Transplantation. 104:S141-S141